课题基金 / 基金详情

IMPACT OF 5FU ON THE STRUCTURE OF THE U4/U6 COMPLEX

IMPACT OF 5FU ON THE STRUCTURE OF THE U4/U6 COMPLEX
5FU 对 U4/U6 复合体结构的影响
批准号:
6325121
负责人:
William H Gmeiner
金额:
$18.92万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-16 至 2001-06-30

项目摘要

项目成果

William H Gmeiner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: One of the largest gaps in our knowledge concerning how the widely used anticancer drug 5-fluorouracil (5-FU) disrupts the RNA mediated processes is to what extent protein-RNA interactions are perturbed when uridine (s) (Urd) in the protein recognition site(s) of the RNA are substituted with FUrd. In this application the hypothesis will be tested that FUrd substitution in the Urd-rich Sm binding site of U4 snRNA disrupts recognition of U4 snRNA by the snRNP core proteins (Sm proteins: B, D1, D2, D3, E, F, and G), a collection of basic proteins named for their relative mobilities during SDS-PAGE. Each of the spliceosomal snRNAs (except U6 snRNA) contains an Sm binding site (consensus sequence in S. cerevisae = AAUUUUUGG). Failure of U4 snRNA to bind to the Sm complex would reduce the efficiency of U4 snRNA nuclear transport and inhibit formation of the spliceosome. Recent studies measuring the biological effects of mutations in U4 snRNA indicate virtually no tolerance for nucleotide substitution in the Sm binding site, suggesting adoption of a rigid recognition code between the Sm protein complex and the Sm binding site. It will be determined if FUrd substitution at and near the Sm binding site of U4 snRNA disrupts the structure and stability of this region of U4 snRNA or if it affects complexation of U4 snRNA with Sm proteins. This will be done by: 1) determining the three dimensional structure for the 3' region of U4 snRNA from S. cerevisae using multidimensional NMR spectroscopy in conjunction with molecular modeling; 2) assessing the effects of FUrd substitution on the structure, stability, and dynamics of the 3' region of U4 snRNA using NMR spectroscopy, nuclease probing, and UV hyperchromicity studies; 3) demonstrating that single nucleotide mutations in the Sm binding site for U4 snRNA decrease the affinity of the RNA for the Sm protein complex by immunoblotting 32P- labeled U4 snRNA that has been incubated with yeast cytosolic extract with Y12, an antibody specific for Sm protein from S. cerevisae; and 4) demonstrating that FUrd substitution in the Sm binding site of U4 snRNA disrupts RNA-protein complex formation also using immunoblotting procedures. These studies will provide novel information concerning the native structure of the 3' region of U4 snRNA, the effects of native nucleotide substitution on Sm complex formation and the effects of FUrd substitution on the structure and stability of U4 snRNA and its complex with Sm proteins.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
相对于 5-FU,FdUMP[10] 的细胞毒性增加,体内毒性降低。
DOI: 10.1080/07328319908044843
发表时间: 1999
期刊: Nucleosides & nucleotides
影响因子: --
作者: [Liu,J, Skradis,A, Kolar,C, Kolath,J, Anderson,J, Lawson,T, Talmadge,J, Gmeiner,WH]
通讯作者: Gmeiner,WH
Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
FdUMP[10]治疗HT-29人结肠癌异种移植物的疗效和安全性。
DOI: --
发表时间: 2002
期刊: International journal of oncology
影响因子: 5.2
作者: [Liu,Changnian, Willingham,Mark, Liu,Jinqian, Gmeiner,WilliamH]
通讯作者: Gmeiner,WilliamH
Antineoplastic activity of a novel multimeric gemcitabine-monophosphate prodrug against thyroid cancer cells in vitro.
新型多聚体吉西他滨-单磷酸前药对甲状腺癌细胞的体外抗肿瘤活性。
DOI: --
发表时间: 2000
期刊: Anticancer research
影响因子: 2
作者: [Kotchetkov,R, Gröschel,B, Gmeiner,WH, Krivtchik,AA, Trump,E, Bitoova,M, Cinatl,J, Kornhuber,B, Cinatl,J]
通讯作者: Cinatl,J
DOI: --
发表时间: 2002-08
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者: [P. Pourquier;C. Gioffre;G. Kohlhagen;Y. Urasaki;F. Goldwasser;L. W. Hertel;Shuyuan Yu;R. Pon;W. Gmeiner;Y. Pommier]
通讯作者: P. Pourquier;C. Gioffre;G. Kohlhagen;Y. Urasaki;F. Goldwasser;L. W. Hertel;Shuyuan Yu;R. Pon;W. Gmeiner;Y. Pommier
Improved Treatment of Colorectal Cancer with CF10
  • 批准号:
    10698394
  • 项目类别:
  • 资助金额:
    $96.45万
  • 财政年份:
    2023
  • 负责人:
    William H Gmeiner
  • 依托单位:
Nanodelivery of FP polymers to improve treatment of metastatic colorectal cancer
Improved Treatment of Colorectal Cancer with CF10 Diversity Supplement
  • 批准号:
    10543218
  • 项目类别:
  • 资助金额:
    $10.45万
  • 财政年份:
    2022
  • 负责人:
    William H Gmeiner
  • 依托单位:
Improved Treatment of Colorectal Cancer with CF10
  • 批准号:
    10254547
  • 项目类别:
  • 资助金额:
    $39.64万
  • 财政年份:
    2021
  • 负责人:
    William H Gmeiner
  • 依托单位:
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: